4
Changes in Ownership
PAVmed Inc. Filed Acc 0001094891-18-000095
Options or other derivatives
- Chairman and CEO acquired 3,968,772 shares (grant or award)
- Chairman and CEO returned 7,937,544 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Aklog Lishan Chairman and CEO | 2018-04-05 | Returned to the company · Warrants | −50,450 | 0 | D: show line 1 in the form | |||||
| Aklog Lishan Chairman and CEO | 2018-04-05 | Grant or award · Series Z Warrants | +25,225 | 25,225 | D: show line 2 in the form | |||||
| Aklog Lishan Chairman and CEO | 2018-04-05 | Returned to the company · Warrants | −5,646,562 | 0 | I: show line 3 in the form | |||||
| Aklog Lishan Chairman and CEO | 2018-04-05 | Grant or award · Series Z Warrants | +2,823,281 | 2,823,281 | I: show line 4 in the form | |||||
| Aklog Lishan Chairman and CEO | 2018-04-05 | Returned to the company · Warrants | −2,220,532 | 0 | I: show line 5 in the form | |||||
| Aklog Lishan Chairman and CEO | 2018-04-05 | Grant or award · Series Z Warrants | +1,110,266 | 1,110,266 | I: show line 6 in the form | |||||
| Aklog Lishan Chairman and CEO | 2018-04-05 | Returned to the company · Warrants | −20,000 | 0 | I: show line 7 in the form | |||||
| Aklog Lishan Chairman and CEO | 2018-04-05 | Grant or award · Series Z Warrants | +10,000 | 10,000 | I: show line 8 in the form |
Loading xslF345X03/edgar.xml…